Kivokast-GT
Description_Effects
Kivokast-GT is a combined medication used to relieve symptoms associated with respiratory diseases like asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). This formulation contains Acebrophylline, Guaifenesin, and Terbutaline Sulphate, which work together to ease breathing and reduce mucus buildup. Acebrophylline acts as a bronchodilator and mucolytic agent. It relaxes the muscles of the airways and helps thin the mucus, making it easier to clear from the lungs. Guaifenesin is an expectorant that increases the flow of mucus, helping to clear congestion and reduce coughing. Terbutaline Sulphate is a bronchodilator that works by relaxing the muscles in the airways, allowing the air passages to open wider and improve airflow. This combination effectively reduces chest tightness, wheezing, and cough associated with excess mucus and airway constriction. It helps patients breathe more comfortably and supports lung function, especially during flare-ups of chronic respiratory conditions. Kivokast-GT should be used as directed by a healthcare professional. Adhering to the prescribed dosage and duration is important for optimal results. Regular monitoring by a doctor ensures safe and effective use of this medicine in managing respiratory symptoms and improving overall respiratory health.
